Individuals infected with HIV have a substantially higher risk of developing cancer compared with uninfected people of the same age. The Anderson laboratory is involved in developing new antiviral therapies to treat HIV infections. A major focus is HIV reverse transcriptase, a viral polymerase essential for HIV replication.<_o3a_p>